Cash Flow - RECURSION PHARMACEUTICALS, INC. (RXRX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -371.81 | -359.17 | -287.78 | -83.52 | -158.61 | -45.40 | -57.04 |
| Cash flow from investing | -16.87 | 260.06 | -10.23 | 193.25 | -271.74 | -8.74 | -3.91 |
| Cash flow from financing | 521.53 | 304.12 | 140.13 | 154.35 | 458.54 | 246.14 | 120.41 |
| Change in cash | 132.85 | 205.01 | -157.88 | 264.07 | 28.18 | 192.00 | 59.46 |
Show Quarterly Cash Flow
Cash Flow - RECURSION PHARMACEUTICALS, INC. (RXRX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -81.10 | -46.07 | -117.36 | -76.42 | -131.96 | -115.43 | -59.23 | -82.22 | -102.30 | -74.08 | -72.92 | -67.47 | -73.32 | -44.75 | -54.54 | -61.62 | 77.39 | -61.16 | -33.05 | -33.65 | -30.76 | 8.57 | -19.46 | -16.70 | -17.82 |
| Cash flow from investing | -0.34 | -1.24 | -2.55 | -5.81 | -7.27 | 275.46 | -4.56 | -4.18 | -6.65 | -2.49 | -0.35 | -2.05 | -5.34 | -7.98 | 52.98 | 4.94 | 143.30 | -52.24 | -193.87 | -6.21 | -19.42 | -4.59 | -3.43 | -0.04 | -0.68 |
| Cash flow from financing | -3.47 | 132.01 | 251.34 | 97.66 | 40.53 | 10.64 | 16.46 | 263.12 | 13.90 | 80.66 | 53.77 | 3.79 | 1.92 | 147.26 | 2.34 | 2.67 | 2.08 | 3.80 | -11.10 | 463.71 | 2.13 | 10.04 | 229.72 | 0.38 | 6.00 |
| Change in cash | -84.91 | 84.69 | 131.43 | 15.43 | -98.70 | 170.67 | -47.33 | 176.72 | -95.06 | 4.09 | -19.50 | -65.73 | -76.73 | 94.53 | 0.78 | -54.02 | 222.78 | -109.61 | -238.02 | 423.84 | -48.04 | 14.02 | 206.84 | -16.36 | -12.50 |